Esperion Therapeutics
ESPR
#7306
Rank
โ‚น46.25 B
Marketcap
โ‚น179.69
Share price
-0.79%
Change (1 day)
131.85%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -โ‚น2.38 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.30 Billion. In 2024 the company made an earning of โ‚น0.71 Billion, an increase over its 2023 earnings that were of -โ‚น14.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.38 Billion-433.86%
2024 โ‚น0.71 B-104.99%
2023 -โ‚น14.25 Billion-15.03%
2022 -โ‚น16.77 Billion-20.61%
2021 -โ‚น21.13 Billion84.28%
2020 -โ‚น11.47 Billion35.75%
2019 -โ‚น8.45 Billion-55.71%
2018 -โ‚น19.07 Billion19.57%
2017 -โ‚น15.95 Billion125.39%
2016 -โ‚น7.08 Billion51.43%
2015 -โ‚น4.68 Billion36.45%
2014 -โ‚น3.43 Billion43.55%
2013 -โ‚น2.39 Billion145.26%
2012 -โ‚น0.98 Billion
2002 -โ‚น2.78 Billion-7.81%
2001 -โ‚น3.01 Billion15.03%
2000 -โ‚น2.62 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น966.45 B-37,241.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น496.00 B-19,161.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น48.27 Billion 1,754.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น6.51 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น18.11 M-100.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น45.75 B-1,858.24%๐Ÿ‡บ๐Ÿ‡ธ USA